Institutional
July 27, 2017
São Paulo Court allows the marketing of generic drug while the patent applications for the reference drug are still pending
Allergan had obtained an injunction preventing the marketing of a generic drug for Combingan®. However, such injunction was revoked because the Trial Court understood in a decision on the merits the owner of pending patent applications does not enjoy exclusive rights. The decision may be subject to an appeal.
Click on Download to access the full text of the decision.
Back
Share:
Last related news
April 18, 2024
Kasznar Leonardos is recognized as a Lexology Legal Influencer Q1 2024
We are honored to announce that Kasznar Leonardos has been recognized as a leading firm in the Lexology Legal Influencers Q1 2024, in the … Kasznar Leonardos is recognized as a Lexology Legal Influencer Q1 2024
April 15, 2024
Kasznar Leonardos takes part in important anti-piracy raids around Brazil
In the last few weeks, Kasznar Leonardos’ Antipiracy & Brand Protection team took part in significant raids against counterfeiters, providing support to … Kasznar Leonardos takes part in important anti-piracy raids around Brazil
April 4, 2024
Kasznar Leonardos is ranked by Chambers & Partners: Contentious 2024
We are pleased to announce that we have been ranked by Chambers and Partners: Contentious 2024! As a firm, we have received … Kasznar Leonardos is ranked by Chambers & Partners: Contentious 2024